We are the leading transatlantic small molecule contract research and manufacturing organization that has been a trusted global partner for biotech and pharma companies for over 30 years.

About us

Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug discovery and development challenges.

With over 600 highly educated scientists in six locations in Europe and two in the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care.

Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. Making Molecules Matter. Together.

Read more

Why work with us?

Symeres offers a range of services in the fields of integrated drug discovery and development, from early hit synthesis to GMP manufacturing, via medicinal chemistry, in vitro pharmacology assays, ADME-Tox and PK via our Admescope platform, process research and development and supporting early formulation and solid-state chemistry. All underpinned by consolidated experience in the custom synthesis services.

  • World-class expertise in innovative drug discovery, drug development and synthetic organic chemistry
  • >30 years track record of successful project progression for our clients
  • High staff retention means highly experienced teams
  • Creative and adaptive problem-solving
  • Excellence in communication
  • Trusted partner network for additional platforms
  • Laboratories in Europe and United States
Work

What do our clients say?

Hear firsthand accounts of how we’re driving success in our customers’ programs!

“Through our dedicated FTE resource at Symeres we have achieved remarkable results, not only by developing a new “aspirational” synthetic route but also by significantly improving the current one to deliver a sustainable route for commercial production and giving us two options for late development.”

– Associate Director, Large Pharma, Europe

“If the compound can be made, Symeres will undoubtedly find out a good way to make it.”

– Dooyoung Jung, CEO of Pinotbio

“The progression was really phenomenal. I am truly impressed. There is a world of difference between you and other CROs.” 

– Biotech Start-up Founder

 

View our Testimonials

Latest news

Below are a few of our most recent news items.

Read more articles

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us